Insider Transactions in Q4 2024 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
21,787
-0.49%
|
$435,740
$20.23 P/Share
|
|
Dec 11
2024
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect |
21,787
-0.49%
|
$435,740
$20.23 P/Share
|
|
Dec 10
2024
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
22,935
-0.52%
|
$458,700
$20.77 P/Share
|
|
Dec 10
2024
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect |
22,935
-0.52%
|
$458,700
$20.77 P/Share
|
|
Dec 03
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
11,703
-7.47%
|
$234,060
$20.15 P/Share
|
|
Dec 02
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
4,088
-2.54%
|
$81,760
$20.26 P/Share
|
|
Dec 02
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.34%
|
$100,000
$20.0 P/Share
|
|
Dec 02
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.96%
|
$10,000
$2.1 P/Share
|
|
Nov 29
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$2,000
$20.0 P/Share
|
|
Nov 29
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.34%
|
$19,000
$19.97 P/Share
|
|
Nov 29
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.32%
|
$2,000
$2.1 P/Share
|
|
Nov 13
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
2,700
-1.65%
|
$54,000
$20.04 P/Share
|
|
Nov 11
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,637
-10.47%
|
$164,103
$19.98 P/Share
|
|
Nov 11
2024
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.78%
|
$12,000
$2.1 P/Share
|
|
Nov 11
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
1,409
-0.85%
|
$28,180
$20.01 P/Share
|
|
Nov 06
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
12,299
-3.51%
|
$233,681
$19.01 P/Share
|
|
Nov 05
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
5,171
-2.83%
|
$93,078
$18.18 P/Share
|
|
Nov 04
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
749
-0.41%
|
$13,482
$18.02 P/Share
|
|
Oct 16
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.33%
|
$10,800
$18.0 P/Share
|